首页|微小RNA-20b-5p/E2F转录因子5介导转化生长因子-β1调节前列腺癌细胞上皮-间充质转化的作用机制研究

微小RNA-20b-5p/E2F转录因子5介导转化生长因子-β1调节前列腺癌细胞上皮-间充质转化的作用机制研究

扫码查看
目的 探讨前列腺癌细胞中微小RNA(miR)-20b-5p/E2F转录因子5(E2F5)介导转化生长因子-β1(TGF-β1)调节前列腺癌细胞上皮-间充质转化(EMT),从而促进前列腺癌发生发展的作用机制.方法 分析数据库,预测miR-20b-5p的靶基因,双荧光报告基因检测miR-20b-5p对E2F5 mRNA的3'UTR的靶向抑制.E2F5的野生型(WT)及突变型(Mut)的3'端非编码区(3'UTR)分别转染PC3和DU145细胞后,再做TGF-β处理,双荧光报告基因检测E2F5是否是TGF-β和miR-20b-5p的共同靶点.蛋白质印迹法(Western blot)检测miR-20b-5p对E2F5的靶调节.PC3和DU145细胞分别转染miR-20b-5p抑制剂和模拟物及其对照RNA后,Western blot检测miR-20b-5p对E2F5的靶调节.分别取两组前列腺增生和前列腺癌组织进行mRNA基因测序,比较两者E2F5的表达.PC3细胞敲低miR-20b-5p的同时也敲低E2F5,Western blot检测EMT相关基因E-钙黏蛋白(E-cadherin)及波形蛋白(Vimentin)表达.组间比较应用单因素方差分析.结果 预测到的靶基因共有207个,并最终确定E2F5为我们的研究对象,双荧光报告基因检测发现与对照组比较miR-20b-5p 对 E2F5 mRNA 的 3'UTR 的靶向抑制作用(PC3 为 103.00±2.00 比 35.67±2.51,F=1 316.258,P<0.01;DU145 为 101.00±2.00 比 69.33±1.53,F=475,P<0.01).与对照组比较TGF-β 对 E2F5 mRNA 的 3'UTR 的靶向增强作用(PC3 为 98.67±2.08 比 155.67±2.08,F=1 124.654,P<0.01;DU145 为 97.33±0.58 比 143.00±2.00,F=1 443.769,P<0.01),E2F5 是TGF-β和miR-20b-5p的共同靶点.PC3和DU145细胞分别转染miR-20b-5p抑制剂和模拟物及其对照RNA后,miR-20b-5p抑制物组E2F5表达高于对照组(PC3组为1.23±0.16比0.83±0.02,P<0.01;DU145 组为 0.49±0.2 比 0.31±0.02,P<0.01),相反,miR-20b-5p 抑制物组 E2F5 表达低于对照组(PC3 组为 0.63±0.02 比 0.82±0.02,P<0.01.DU145 组为 0.14±0.02 比 0.30±0.02,P<0.01),说明miR-20b-5p对E2F5的靶向负调节作用.mRNA基因测序发现E2F5在前列腺癌中表达显著高于对照组,并且分析TCGA数据库显示E2F5在前列腺癌组织中高表达.敲低miR-20b-5p后E-cadherin的表达低于对照组,而同时敲低E2F5后又能够扭转这个趋势[分别为0.43±0.02和0.98±0.02,与对照组(0.95±0.02)比较,F=817.515,P<0.01],与之相反,敲低 miR-20b-5 p,Vimentin的表达高于对照组,而同时敲低E2F5后又能够扭转这个趋势[分别为0.75±0.02和0.18±0.02,与对照组(0.15±0.02)比较,F=832.089,P<0.01],说明 E2F5 通过靶向调控 E2F5 从而调控EMT表型蛋白E-cadherin及Vimentin表达,导致前列腺癌的发生发展.结论 miR-20b-5p/E2F5介导TGF-β1调节前列腺癌细胞EMT的作用从而导致前列腺癌的进展.
Mechanism of microRNA-20b-5p/E2F transcription factor 5-mediated regulation of epithelial-mesenchymal transition by transforming growth factor-β in prostate cancer cells
Objective To explore the mechanism of microRNA(miR)-20b-5p/E2F transcription factor 5(E2F5)-mediated regulation of epithelial-mesenchymal transition(EMT)by transfonning growth factor(TGF)-β1 in prostate cancer cell line,further promoting dhe occurrence and development of prostate cancer.Methods The database was analyzed,the target gene of miR-20b-5p was predicted,and the tar-geted inhibition of 3'UTR of E2F5 mRNA by miR-20b-5p was detected by double fluorescence reporter gene.Wild type(WT)and mutant(Mut)of E2F5 3'UTR were transfected into PC3 and DU145 cells,re-spectively,and then cells were treated with TGF-β.Double fluorescence reporter gene was used to detect whether E2F5 was the common target of TGF-β and miR-20b-5p.The target regulation of E2F5 by miR-20b-5p was detected by Western blotting.After PC3 and DU145 cells were transfected with miR-20b-5p inhibitor,mimic and control RNA respectively,the target regulation of E2F5 by miR-20b-5p was detected by Western blotting.MRNA gene was sequenced in benign prostatic hyperplasia and prostate cancer tissues of two groups,and the expression of E2F5 was compared between the two groups.miR-20b-5p and E2F5 were knocked down in PC3 cells.The expression of EMT-related genes E-cadherin and Vimentin was de-tected by Western blotting.The experimental data were expressed by mean±standard deviation,and one-way ANOVA was used for comparison between groups.Results A total of 207 target genes were predic-ted,and E2F5 was finally determined as our object of study.Double fluorescence reporter gene test found the miR-20b-5p targeted inhibition of E2F5 mRNA 3'UTR compared with the control group(PC3:103.00±2.00 vs.35.67±2.51,F=1 316.258,P<0.01;DU145:101.00±2.00 vs.69.33±1.53,F=475,P<0.01).Compared with the control group,the targeted effect of TGF-β on 3'UTR of E2F5 mRNA was enhanced(PC3:98.67±2.08 vs.155.67±2.08,F=1 124.654,P<0.01;DU145:97.33±0.58 vs.143.00±2.00,F=1 443.769,P<0.01).E2F5 was the common target of TGF-β and miR-20b-5p.After PC3 and DU145 cells were transfected with miR-20b-5p inhibitor,mimic and control RNA,the expression of E2F5 in miR-20b-5p inhibitor group was higher than that in control group(PC3:1.23±0.16 vs.0.83±0.02;DU145:0.49±0.2 vs.0.31±0.02,P<0.01).The expression of E2F5 in miR-20b-5p inhibitor group was lower than that in the control group(PC3:0.63±0.02 vs.0.82± 0.02;DU145:0.14±0.02 vs.0.30±0.02,P<0.01).MRNA gene sequencing showed that the expres-sion of E2F5 in prostate cancer was higher than that in the control group,and the analysis of TCGA data-base showed that E2F5 was highly expressed in prostate cancer.After knocking down miR-20b-5p,the ex-pression of E-cadherin was lower than that of the control group,while knocking down E2F5 at the same time could reverse this trend(0.43±0.02 and 0.98±0.02 vs.0.95±0.02,P<0.01).After knocking down the expression of miR-20b-5p,Vimentin was higher than that in the control group,while knocking down E2F5 at the same time could reverse this trend(0.75±0.02 and 0.18±0.02 vs.0.15±0.02,P<0.01),indicating that E2F5 regulates the expression of EMT phenotypic protein E-cadherin and Vimentin through targeted regulation of E2F5,leading to the occurrence and development of prostate cancer.Conclusion MiR-20b-5p/E2F5 mediates the regulation of TGF-β1 on prostate cancer cell line EMT,which leads to the progression of prostate cancer.

Prostate cancerE2F transcription factor 5Transforming growth factor-β1Epithelial-mesenchymal transition

杜蕾、马子越、常学良、薛文勇、齐进春

展开 >

河北医科大学第二医院泌尿外科,石家庄 050000

前列腺癌 E2F转录因子5 转化生长因子-β1 上皮-间充质转化

河北自然科学基金河北自然科学基金

H2022206185H2020206109

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(1)
  • 13